#biontech
2 stories
BioNTech SE Shifts Focus
BioNTech SE pivots from pandemic vaccines to oncology with $19B cash and 33 trials.
Seekingalpha · 1m
Moderna Jumps 9% After Melanoma Data Wins Prestigious Slot
Moderna stock surges 9% as Phase 3 melanoma trial data secures top presentation slot at major cancer conference
24/7 Wall St. · 1m